These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 23345409)

  • 41. Analyzing the potential for incorrect haplotype calls with different pharmacogenomic assays in different populations: a simulation based on 1000 Genomes data.
    Samwald M; Blagec K; Hofer S; Freimuth RR
    Pharmacogenomics; 2015; 16(15):1713-21. PubMed ID: 26419264
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 4th Annual Pharmacogenomics and Medicine Lectures.
    Oestreicher P
    Pharmacogenomics; 2001 Aug; 2(3):291-6. PubMed ID: 11939134
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacogenomics: the promise of personalized medicine.
    Mancinelli L; Cronin M; Sadée W
    AAPS PharmSci; 2000; 2(1):E4. PubMed ID: 11741220
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacogenetics, pharmacogenomics, and individualized medicine.
    Ma Q; Lu AY
    Pharmacol Rev; 2011 Jun; 63(2):437-59. PubMed ID: 21436344
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chapter 7: Pharmacogenomics.
    Karczewski KJ; Daneshjou R; Altman RB
    PLoS Comput Biol; 2012; 8(12):e1002817. PubMed ID: 23300409
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Building individualized medicine: prevention of adverse reactions to warfarin therapy.
    Krynetskiy E; McDonnell P
    J Pharmacol Exp Ther; 2007 Aug; 322(2):427-34. PubMed ID: 17496169
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Host genetic profiling to increase drug safety in colorectal cancer from discovery to implementation.
    Cecchin E; De Mattia E; Ecca F; Toffoli G
    Drug Resist Updat; 2018 Jul; 39():18-40. PubMed ID: 30075835
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacogenomics in dermatology: from susceptibility genes to personalized therapy.
    Pincelli C; Pignatti M; Borroni RG
    Exp Dermatol; 2009 Apr; 18(4):337-49. PubMed ID: 19348000
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacogenomics: historical perspective and current status.
    Charlab R; Zhang L
    Methods Mol Biol; 2013; 1015():3-22. PubMed ID: 23824846
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Using pharmacogenetics and pharmacogenomics in the treatment of psychiatric disorders: some ethical and economic considerations.
    Morley KI; Hall WD
    J Mol Med (Berl); 2004 Jan; 82(1):21-30. PubMed ID: 14598045
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Healthcare provider education to support integration of pharmacogenomics in practice: the eMERGE Network experience.
    Rohrer Vitek CR; Abul-Husn NS; Connolly JJ; Hartzler AL; Kitchner T; Peterson JF; Rasmussen LV; Smith ME; Stallings S; Williams MS; Wolf WA; Prows CA
    Pharmacogenomics; 2017 Jul; 18(10):1013-1025. PubMed ID: 28639489
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Canadian Pharmacogenomics Network for Drug Safety: a model for safety pharmacology.
    Ross CJ; Visscher H; Sistonen J; Brunham LR; Pussegoda K; Loo TT; Rieder MJ; Koren G; Carleton BC; Hayden MR;
    Thyroid; 2010 Jul; 20(7):681-7. PubMed ID: 20578893
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Drug therapy and pharmacogenomics--hopes and facts].
    Müller-Zellenberg U; Müller M
    Wien Med Wochenschr; 2005 Feb; 155(3-4):45-9. PubMed ID: 15791775
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacogenetics of the G protein-coupled receptors.
    Thompson MD; Cole DE; Capra V; Siminovitch KA; Rovati GE; Burnham WM; Rana BK
    Methods Mol Biol; 2014; 1175():189-242. PubMed ID: 25150871
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacogenomic-Based Decision Support to Predict Adherence to Medications.
    Christian C; Borden BA; Danahey K; Yeo KJ; van Wijk XMR; Ratain MJ; O'Donnell PH
    Clin Pharmacol Ther; 2020 Aug; 108(2):368-376. PubMed ID: 32236960
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The pharmacogenetics of medications used in general anesthesia.
    Xie S; Ma W; Guo Q; Liu J; Li W; McLeod HL; He Y
    Pharmacogenomics; 2018 Feb; 19(3):285-298. PubMed ID: 29318929
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A conceptual framework for pharmacodynamic genome-wide association studies in pharmacogenomics.
    Wu R; Tong C; Wang Z; Mauger D; Tantisira K; Szefler SJ; Chinchilli VM; Israel E
    Drug Discov Today; 2011 Oct; 16(19-20):884-90. PubMed ID: 21920452
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Highly personalized reports for personalized drug selection by expert systems as clinical decision support.
    Hizel HC
    Per Med; 2017 Mar; 14(2):93-97. PubMed ID: 29754552
    [No Abstract]   [Full Text] [Related]  

  • 59. Benefits of pharmacogenomics in drug development-earlier launch of drugs and less adverse events.
    Ohashi W; Tanaka H
    J Med Syst; 2010 Aug; 34(4):701-7. PubMed ID: 20703925
    [TBL] [Abstract][Full Text] [Related]  

  • 60. DruGeVar: an online resource triangulating drugs with genes and genomic biomarkers for clinical pharmacogenomics.
    Dalabira E; Viennas E; Daki E; Komianou A; Bartsakoulia M; Poulas K; Katsila T; Tzimas G; Patrinos GP
    Public Health Genomics; 2014; 17(5-6):265-71. PubMed ID: 25228099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.